Literature DB >> 29680172

Optimal Timing of Percutaneous Coronary Intervention in Patients With Non-ST-Segment Elevation Myocardial Infarction Complicated by Acute Decompensated Heart Failure (from the Korea Acute Myocardial Infarction Registry-National Institutes of Health [KAMIR-NIH]).

Min Chul Kim1, Myung Ho Jeong2, Doo Sun Sim1, Young Joon Hong1, Ju Han Kim1, Youngkeun Ahn1, Tae Hoon Ahn3, Ki Bae Seung4, Dong-Joo Choi5, Hyo-Soo Kim6, Hyeon Cheol Gwon7, In Whan Seong8, Kyung Kuk Hwang9, Shung Chull Chae10, Seung Ho Hur11, Kwang Soo Cha12, Seok Kyu Oh13, Jei Keon Chae14.   

Abstract

The optimal timing of percutaneous coronary intervention (PCI) in patients with non-ST-segment elevation myocardial infarction (NSTEMI), complicated by acute decompensated heart failure (ADHF), is unclear. A total of 1,027 patients with NSTEMI complicated by ADHF who underwent successful PCI were analyzed using a Korean multicenter registry. All patients were divided into 4 groups by the timing of PCI: group 1 (PCI < 2 hour after admission, n = 149), group 2 (2 to 24 hours, n = 577), group 3 (24 to 72 hours, n = 189), and group 4 (≥72 hours, n = 112). We analyzed the incidences of 12-month mortality, nonfatal myocardial infarction (MI), target-vessel revascularization, and rehospitalization because of HF. The prevalence of ADHF in patients with NSTEMI was 15.2% at initial presentation, and in-hospital mortality was higher in group 1 than in the other groups. There were no significant differences in mortality, nonfatal MI, target-vessel revascularization, or rehospitalization for HF during the 12-month follow-up between groups, regardless of initial PCI timing, except for a higher 12-month mortality in patients who received PCI within 24 hours (vs ≥24 hours) (hazard ratio 1.52, 95% confidence interval 1.09 to 2.29, p = 0.046). Early PCI did not reduce adverse clinical outcomes in patients with NSTEMI complicated by ADHF. Delayed PCI after stabilization may be reasonable in such high-risk patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29680172     DOI: 10.1016/j.amjcard.2018.01.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Comparison of early and delayed invasive strategies in short-medium term among patients with non-ST segment elevation acute coronary syndrome: A systematic review and meta-analysis.

Authors:  Ming-Bo Zhang; Chen Guo; Min Li; Yong-Hui Lv; Yu-Dong Fan; Zhi-Lu Wang
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

Review 2.  Drug-eluting balloon: is it useful?

Authors:  Sidhi Laksono; Budhi Setianto; Steven Philip Surya
Journal:  Egypt Heart J       Date:  2020-11-11

Review 3.  2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction.

Authors:  Kiyuk Chang; Youngkeun Ahn; Sungmin Lim; Jeong Hoon Yang; Kwan Yong Lee; Eun Ho Choo; Hyun Kuk Kim; Chang Wook Nam; Weon Kim; Jin Yong Hwang; Seung Woon Rha; Hyo Soo Kim; Myeong Chan Cho; Yangsoo Jang; Myung Ho Jeong
Journal:  Korean Circ J       Date:  2021-04       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.